Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates.
暂无分享,去创建一个
Nuna C. P. Araújo | V. Barton | P. Stocks | M. L. Cristiano | A. Shone | S. Ward | P. O’Neill | P. Bray | Victoria E. Barton | Paul A. Stocks | Jill Davies | Michael Jones | Nuna C. Araújo | M. L. S. Cristiano
[1] B. Mordmüller,et al. Selection of a trioxaquine as an antimalarial drug candidate , 2008, Proceedings of the National Academy of Sciences.
[2] B. Meunier,et al. Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.
[3] S. Kappe,et al. Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.
[4] Ruth H. Hughes,et al. Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. , 2007, Angewandte Chemie.
[5] J. Karle,et al. Weak base dispiro-1,2,4-trioxolanes: potent antimalarial ozonides. , 2007, Bioorganic & medicinal chemistry letters.
[6] J. Lelièvre,et al. Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including Gametocytes , 2007, Antimicrobial Agents and Chemotherapy.
[7] J. Chollet,et al. Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes. , 2006, Bioorganic & medicinal chemistry.
[8] S. Krishna,et al. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance , 2006, Trends in molecular medicine.
[9] B. Meunier,et al. The key role of heme to trigger the antimalarial activity of trioxanes , 2005 .
[10] J. Karle,et al. Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes. , 2005, Journal of medicinal chemistry.
[11] J. K. Wood,et al. Dispiro-1,2,4-trioxane analogues of a prototype dispiro-1,2,4-trioxolane: mechanistic comparators for artemisinin in the context of reaction pathways with iron(II). , 2005, The Journal of organic chemistry.
[12] Richard K. Haynes Prof.. Reply to Comments on “Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity” , 2005 .
[13] Christian Scheurer,et al. Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.
[14] Yuxiang Dong,et al. Synthetic peroxides as antimalarials , 2004, Medicinal research reviews.
[15] P. O’Neill,et al. A medicinal chemistry perspective on artemisinin and related endoperoxides. , 2004, Journal of medicinal chemistry.
[16] P. O’Neill,et al. Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides. , 2004, Accounts of chemical research.
[17] H. Vial,et al. Synthesis and antimalarial activity of trioxaquine derivatives. , 2004, Chemistry.
[18] S. Croft,et al. Highly antimalaria-active artemisinin derivatives: biological activity does not correlate with chemical reactivity. , 2004, Angewandte Chemie.
[19] S. Puri,et al. Synthesis and antimalarial activity of a new series of trioxaquines. , 2004, Bioorganic & medicinal chemistry.
[20] Dominic P. Williams,et al. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin. , 2004, Journal of medicinal chemistry.
[21] S. Krishna,et al. Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.
[22] J. Craig,et al. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. , 2003, The Journal of antimicrobial chemotherapy.
[23] B. Meunier,et al. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. , 2002, Accounts of chemical research.
[24] B. K. Park,et al. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues. , 2002, Journal of medicinal chemistry.
[25] B. K. Park,et al. Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues , 2001 .
[26] B. Meunier,et al. In Vitro Activities of DU-1102, a New Trioxaquine Derivative, against Plasmodium falciparum Isolates , 2001, Antimicrobial Agents and Chemotherapy.
[27] B. Meunier,et al. Preparation and Antimalarial Activities of “Trioxaquines”, New Modular Molecules with a Trioxane Skeleton Linked to a 4‐Aminoquinoline , 2000, Chembiochem : a European journal of chemical biology.
[28] R. Snow,et al. Averting a malaria disaster , 1999, The Lancet.
[29] N. White,et al. Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[30] B. K. Park,et al. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin. , 1996, Journal of medicinal chemistry.
[31] S. Grate,et al. Fatal neurotoxicity of arteether and artemether. , 1994, The American journal of tropical medicine and hygiene.
[32] S. Meshnick,et al. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) , 1993, Antimicrobial Agents and Chemotherapy.
[33] S. Meshnick,et al. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. , 1991, Molecular and biochemical parasitology.
[34] D. L. Klayman,et al. Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .
[35] J. Haynes,et al. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.
[36] W. Trager,et al. Cultivation of malarial parasites , 1978, Nature.